Alpha Tau Medical Ltdis A Clinical Stage Oncology Therapeutics Company Based In Jerusalemisraelfounded In 2016The Company Specializes In Developing And Commercializing Diffusing Alpha Emitters Radiation Therapyalpha Dartfor Treating Solid Tumorsthis Innovative Therapy Uses Radium 224 Coated Seeds That Emit Short Range Alpha Radiationallowing For Targeted Treatment Of Cancers While Minimizing Damage To Surrounding Healthy Tissue Alpha Tau Is Actively Conducting Clinical Trials For Various Tumor Typesincluding Skinoralpancreaticprostatelungliverand Breast Cancersthe Company Has Received Fda Approval For Trials In Newly Diagnosed Pancreatic Cancer And Recurrent Cutaneous Squamous Cell Carcinoma In Immunocompromised Patientswith A Focus On Precision And Immune Activationalpha Dart Aims To Achieve Tumor Necrosis And Potentially Stimulate Systemic Immune Responses Against Cancer Cellsthe Company Is Expanding Its Production Capabilities In Hudsonnew Hampshirewith Plans To Operationalize Alpha Dart Production By Late 2025
